基于临床和病理特征的严重免疫相关肝毒性的管理和治疗
Nan Zhang1, Zhaohui Li2, Yutao Liu3
1Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Beijing, 100730, China.
Hepatology international
|July 2, 2024
概括
严重的免疫相关肝毒性 (irH) 管理需要优化. PD-L1 抑制剂降低了 irH 的风险,对于 4 级 irH 需要更高的 GCS 剂量,并且在 irH 后,免疫检查点抑制剂的重新挑战是安全的.
科学领域:
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
背景情况:
- 严重的免疫相关肝毒性 (irH) 管理需要优化.
- 了解临床特征和改善类固醇耐火性irrH的救援疗法至关重要.
- 重要的是评估免疫检查点抑制剂 (ICPi) 重复挑战的安全性.
研究的目的:
- 分析严重的IRH的临床特征.
- 优化治疗策略,重点是救援治疗类固醇耐火性IRH.
- 确定ICPI重新挑战在患有之前严重IRH的患者中的安全性.
主要方法:
- 在接受ICPis.患者的多中心回顾性研究.
- 使用倾向性得分匹配,比较患有和没有严重的IRH的患者.
- 分析治疗策略,包括葡萄糖皮质类药物和免疫抑制,以及ICPI重新挑战结果.
主要成果:
- 在5,326名患者中,51名患者在ICPI治疗后出现了严重的IRH.
- PD-L1 抑制剂与较低的严重IRH风险有关.
- 在4级IRH和类固醇耐药病例中,需要更高的GCS剂量; ICPi重新挑战是安全的,没有复发.
结论:
- 严重的IrH需要一个多维的评估方法.
- PD-L1抑制剂显示出严重的IRH风险降低.
- 对于4级的irH,需要高于推的GCS剂量,而ICPI重新挑战是可行的和安全的.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
Acute Pancreatitis II: Clinical Manifestations and Management
118
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
118
Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84
Prevention of Further Absorption of Poison
810
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
810
Cell-mediated Immune Responses
68.1K
Overview
68.1K


